Maca

Maca (Lepidium meyenii) is a small biennial cruciferous plant in the Brassicaceae family, cultivated for more than two thousand years on the high Andean plateau of central Peru at elevations of three thousand five hundred to four thousand five hundred metres. The turnip-shaped root is the edible and medicinal part, traditionally dried, boiled, or roasted before consumption. Three main colour phenotypes are grown side by side in the same fields: yellow (most common, generally consumed as food), red (higher glucosinolate content), and black (highest macamide content). Andean households use the three colours differently in traditional practice.

In the modern Western market Maca is sold as a powder, a gelatinised powder, capsules, fluid extract, and as a flavour component in chocolate and protein blends. It has no European Medicines Agency monograph and no EFSA-permitted health claim. The herb is best understood as a traditional Andean root staple and supplement with a small modern research base on sexual function, energy, and menopausal symptoms, rather than as a clinical treatment for any condition.

Maca has been cultivated for at least two thousand years on the Bombon and Junin plateaus of central Peru, at altitudes where few other crops can grow. Pre-Inca and Inca-era communities used the dried root as a staple food source, prepared as a porridge, fermented drink (chicha de maca), or boiled with milk and sweetened. Spanish colonial records from the sixteenth century describe Maca as a tribute crop accepted in lieu of taxes and note its reputed value for fertility in both humans and livestock kept at altitude. The plant has been a continuous part of Andean food culture since.

Maca is not part of the European or Austrian Hausmittel canon and has no historical place in the Commission E or EMA HMPCEuropean Medicines Agency, Committee on Herbal Medicinal Products (HMPC) literature. It arrived in central European markets only in the late twentieth and early twenty-first century, primarily as a modern superfood import on the back of small clinical studies and traditional-Andean marketing. The honest framing is that Maca is a Peruvian Andean root food with a long ethnobotanical record and a small modern research base, not a herb of any European tradition.

The characteristic bioactive groups in Maca are the macamides and macaenes, a family of long-chain fatty acid derivatives unique to the species and concentrated in the dried root. The black phenotype carries the highest macamide content, the red phenotype the highest glucosinolate content; yellow Maca sits between the two. Glucosinolates are characteristic of the Brassicaceae (cruciferous) family, the same chemical family as mustard, broccoli, and watercress, and account for the slightly pungent flavour of raw Maca powder. Sterols (including campesterol and beta-sitosterol) are present at lower levels.

Proposed mechanisms for Maca are based largely on cell-culture and rodent studies, with much less direct evidence in humans. The macamides have been studied for potential cannabinoid receptor activity in vitro; the glucosinolates and their breakdown products are common to all Brassicaceae plants and account for the characteristic family-wide goitrogen activity at high doses. The link between any individual Maca compound and a clinical effect in people is not firmly established. Maca is best read as a traditional Andean root food with an emerging modern research base, not as a herb with a defined pharmacology.

The modern clinical research base on Maca is small and concentrated on three areas: sexual function, energy and stamina, and menopausal symptoms. Shin and colleagues published a 2010 systematic review of randomised trials on Maca for sexual dysfunction, identifying a handful of small short studies and reporting a modest signal across heterogeneous designs and product types. Gonzales and colleagues published a 2002 randomised controlled trial in adult Peruvian men reporting changes in semen parameters over twelve weeks of Maca powder consumption. Both bodies of work are small, the populations were narrow, and the products tested were not always equivalent.

Stojanovska and colleagues published a 2015 randomised controlled trial of Maca in postmenopausal women, reporting reductions in self-reported menopausal symptoms and improvements in mood markers. EFSA has not granted a permitted health claim for Maca for any indication. The honest summary is that the modern evidence is heterogeneous, the trials are small, and the product variability across yellow, red, black, raw, and gelatinised forms is large. Maca is best read as a traditional Andean food with an emerging research base, not as a clinical treatment.

Forms and preparation

Maca is sold in several forms. Plain Maca powder is the closest to the traditional dried root; it has a malty, slightly cruciferous flavour and is typically stirred into smoothies, porridge, or warm milk at a teaspoon to a tablespoon per serving. Gelatinised Maca powder has been gently cooked under pressure to break down the starch granules and reduce the goitrogenic glucosinolate load; it is easier to digest and is the form most traditional Andean consumers prefer. Capsules, fluid extract, and Maca chocolate are common modern presentations on the European market. For everyday use take gelatinised powder rather than raw. Andean tradition cooks the root before eating it (boiled, roasted, or fermented); raw Maca powder is a modern Western invention and can cause mild gastrointestinal discomfort or bloating, especially at higher doses. Mix Maca with food rather than taking it on an empty stomach. If you are choosing by colour, yellow is the everyday food form, red is traditionally used for cycle and bone-related concerns, and black for energy and stamina; the colour-specific differences are real in the bioactive profile but the human evidence on differential effect is small.

Dosage

A typical daily dose of Maca powder is one and a half to three grams, taken with food. The Gonzales 2002 trial used one and a half grams per day of dried root powder; many subsequent trials sit in the range of one and a half to three grams. Capsules at three hundred to five hundred milligrams of concentrated extract per day are sold as an alternative, but the relationship between raw root powder dose and concentrated extract dose is not standardised across brands. Build up gradually rather than starting at the upper end. Start low. Begin with half a teaspoon (about one and a half grams) of gelatinised Maca powder mixed into food for the first week and see how you tolerate it before increasing. Take Maca with a meal rather than on an empty stomach. There is no formally established maximum safe duration of use; traditional Andean consumption is daily, but the longer-term modern data is limited, and pulses of eight to twelve weeks with a break are a sensible default for supplemental use.